Snowden Capital Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Snowden Capital Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,074	Closed	-$268K	–	1195
2022 Q4	$268K	Sell	5,074 -100	-2%	-$4.87K	0.01%	963
2022 Q3	$232K	Buy	+5,174	New	+$223K	0.01%	984
2022 Q2	–	Sell	-5,393	Closed	-$222K	–	1189
2022 Q1	$222K	Buy	5,393 +4,283	+386%	+$151K	0.01%	939
2021 Q4	$47K	Buy	+1,110	New	+$55.5K	﹤0.01%	1059

Other funds holding SILK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Snowden Capital Advisors's SILK Position: Q1 2023 in Review

Snowden Capital Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2023, closing a stake of 5,074 shares — an estimated $268K sold.

Snowden Capital Advisors first reported a position in SILK in Q4 2021 and held it in 4 quarters. The position peaked at $268K in Q4 2022. 194 funds tracked by Wall St. Rank hold SILK as of Q1 2023.

Snowden Capital Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Snowden Capital Advisors sold 5,074 Silk Road Medical, Inc. Common Stock shares in Q1 2023, an estimated $268K.
Snowden Capital Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Snowden Capital Advisors's Silk Road Medical, Inc. Common Stock position peaked at $268K in Q4 2022.
194 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2023.

Based on Snowden Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.